Fate Therapeutics Snags $3 Billion-Plus Deal With Johnson & Johnson
The companies will be collaborating on immuno-oncology treatments. On Thursday after the closing bell, Fate Therapeutics (FATE 1.16%) announced that it …
The companies will be collaborating on immuno-oncology treatments. On Thursday after the closing bell, Fate Therapeutics (FATE 1.16%) announced that it …